Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy

Dekui Zhang, Justin L Mott, Patricia Farrar, Jan S. Ryerse, Shin Wen Chang, Melissa Stevens, Grace Denniger, Hans Peter Zassenhaus

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Objective: To determine whether low frequency mitochondrial DNA (mtDNA) mutations are pathogenic. Methods: We studied mice that express a proofreading-deficient mitochondrial DNA polymerase in the heart and develop cardiac mtDNA mutations. Results: At 4 weeks of age, when point mutation levels had risen to on average two per mitochondrial genome, these mice developed severe dilated cardiomyopathy. Interstitial fibrosis first became apparent at 4 weeks of age and progressed with age. Sporadic myocytic death occurred in all regions of the heart, apparently due to apoptosis as assessed by histological analysis and TUNEL staining. The frequency of TUNEL-positive cells peaked at 4-5 weeks of age and then gradually declined. While mitochondrial respiratory function, ultrastructure, and number remained normal, cytochrome c was released from mitochondria, a known apoptotic signal. Conclusion: mtDNA mutations therefore are pathogenic, and seem to trigger apoptosis through the mitochondrial pathway.

Original languageEnglish (US)
Pages (from-to)147-157
Number of pages11
JournalCardiovascular Research
Volume57
Issue number1
DOIs
StatePublished - Jan 1 2003

Fingerprint

Dilated Cardiomyopathy
Mitochondrial DNA
Mutation
In Situ Nick-End Labeling
Apoptosis
Mitochondrial Genome
DNA-Directed DNA Polymerase
Cytochromes c
Point Mutation
Mitochondria
Fibrosis
Staining and Labeling

Keywords

  • Aging
  • Apoptosis
  • Cardiomyopathy
  • Mitochondria
  • Sequence (DNA/RNA/prot)

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy. / Zhang, Dekui; Mott, Justin L; Farrar, Patricia; Ryerse, Jan S.; Chang, Shin Wen; Stevens, Melissa; Denniger, Grace; Zassenhaus, Hans Peter.

In: Cardiovascular Research, Vol. 57, No. 1, 01.01.2003, p. 147-157.

Research output: Contribution to journalArticle

Zhang, D, Mott, JL, Farrar, P, Ryerse, JS, Chang, SW, Stevens, M, Denniger, G & Zassenhaus, HP 2003, 'Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy', Cardiovascular Research, vol. 57, no. 1, pp. 147-157. https://doi.org/10.1016/S0008-6363(02)00695-8
Zhang, Dekui ; Mott, Justin L ; Farrar, Patricia ; Ryerse, Jan S. ; Chang, Shin Wen ; Stevens, Melissa ; Denniger, Grace ; Zassenhaus, Hans Peter. / Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy. In: Cardiovascular Research. 2003 ; Vol. 57, No. 1. pp. 147-157.
@article{6d41268904be47eb8c4b53b9e4021191,
title = "Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy",
abstract = "Objective: To determine whether low frequency mitochondrial DNA (mtDNA) mutations are pathogenic. Methods: We studied mice that express a proofreading-deficient mitochondrial DNA polymerase in the heart and develop cardiac mtDNA mutations. Results: At 4 weeks of age, when point mutation levels had risen to on average two per mitochondrial genome, these mice developed severe dilated cardiomyopathy. Interstitial fibrosis first became apparent at 4 weeks of age and progressed with age. Sporadic myocytic death occurred in all regions of the heart, apparently due to apoptosis as assessed by histological analysis and TUNEL staining. The frequency of TUNEL-positive cells peaked at 4-5 weeks of age and then gradually declined. While mitochondrial respiratory function, ultrastructure, and number remained normal, cytochrome c was released from mitochondria, a known apoptotic signal. Conclusion: mtDNA mutations therefore are pathogenic, and seem to trigger apoptosis through the mitochondrial pathway.",
keywords = "Aging, Apoptosis, Cardiomyopathy, Mitochondria, Sequence (DNA/RNA/prot)",
author = "Dekui Zhang and Mott, {Justin L} and Patricia Farrar and Ryerse, {Jan S.} and Chang, {Shin Wen} and Melissa Stevens and Grace Denniger and Zassenhaus, {Hans Peter}",
year = "2003",
month = "1",
day = "1",
doi = "10.1016/S0008-6363(02)00695-8",
language = "English (US)",
volume = "57",
pages = "147--157",
journal = "Cardiovascular Research",
issn = "0008-6363",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy

AU - Zhang, Dekui

AU - Mott, Justin L

AU - Farrar, Patricia

AU - Ryerse, Jan S.

AU - Chang, Shin Wen

AU - Stevens, Melissa

AU - Denniger, Grace

AU - Zassenhaus, Hans Peter

PY - 2003/1/1

Y1 - 2003/1/1

N2 - Objective: To determine whether low frequency mitochondrial DNA (mtDNA) mutations are pathogenic. Methods: We studied mice that express a proofreading-deficient mitochondrial DNA polymerase in the heart and develop cardiac mtDNA mutations. Results: At 4 weeks of age, when point mutation levels had risen to on average two per mitochondrial genome, these mice developed severe dilated cardiomyopathy. Interstitial fibrosis first became apparent at 4 weeks of age and progressed with age. Sporadic myocytic death occurred in all regions of the heart, apparently due to apoptosis as assessed by histological analysis and TUNEL staining. The frequency of TUNEL-positive cells peaked at 4-5 weeks of age and then gradually declined. While mitochondrial respiratory function, ultrastructure, and number remained normal, cytochrome c was released from mitochondria, a known apoptotic signal. Conclusion: mtDNA mutations therefore are pathogenic, and seem to trigger apoptosis through the mitochondrial pathway.

AB - Objective: To determine whether low frequency mitochondrial DNA (mtDNA) mutations are pathogenic. Methods: We studied mice that express a proofreading-deficient mitochondrial DNA polymerase in the heart and develop cardiac mtDNA mutations. Results: At 4 weeks of age, when point mutation levels had risen to on average two per mitochondrial genome, these mice developed severe dilated cardiomyopathy. Interstitial fibrosis first became apparent at 4 weeks of age and progressed with age. Sporadic myocytic death occurred in all regions of the heart, apparently due to apoptosis as assessed by histological analysis and TUNEL staining. The frequency of TUNEL-positive cells peaked at 4-5 weeks of age and then gradually declined. While mitochondrial respiratory function, ultrastructure, and number remained normal, cytochrome c was released from mitochondria, a known apoptotic signal. Conclusion: mtDNA mutations therefore are pathogenic, and seem to trigger apoptosis through the mitochondrial pathway.

KW - Aging

KW - Apoptosis

KW - Cardiomyopathy

KW - Mitochondria

KW - Sequence (DNA/RNA/prot)

UR - http://www.scopus.com/inward/record.url?scp=0037214525&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037214525&partnerID=8YFLogxK

U2 - 10.1016/S0008-6363(02)00695-8

DO - 10.1016/S0008-6363(02)00695-8

M3 - Article

VL - 57

SP - 147

EP - 157

JO - Cardiovascular Research

JF - Cardiovascular Research

SN - 0008-6363

IS - 1

ER -